Citations (97)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Yusuke Takahashi, Kazuhiro Oguchi, Yusuke Mochizuki, Ken Takasone, Naoki Ezawa, Akira Matsushima, Nagaaki Katoh, Masahide Yazaki & Yoshiki Sekijima. (2023) Distribution and progression of cerebral amyloid angiopathy in early-onset V30M (p.V50M) hereditary ATTR amyloidosis. Amyloid 30:1, pages 109-118.
Read now
Read now
Yukio Ando, David Adams, Merrill D. Benson, John L. Berk, Violaine Planté-Bordeneuve, Teresa Coelho, Isabel Conceição, Bo-Göran Ericzon, Laura Obici, Claudio Rapezzi, Yoshiki Sekijima, Mitsuharu Ueda, Giovanni Palladini & Giampaolo Merlini. (2022) Guidelines and new directions in the therapy and monitoring of ATTRv amyloidosis. Amyloid 29:3, pages 143-155.
Read now
Read now
Jonathan Schönfelder, Peter Benedikt Pfeiffer, Tejaswini Pradhan, Johan Bijzet, Bouke P. C. Hazenberg, Stefan O. Schönland, Ute Hegenbart, Bernd Reif, Christian Haupt & Marcus Fändrich. (2021) Protease resistance of ex vivo amyloid fibrils implies the proteolytic selection of disease-associated fibril morphologies. Amyloid 28:4, pages 243-251.
Read now
Read now
Urban Hellman, Kenneth Lång, Elisabet Ihse, Jenni Jonasson, Malin Olsson, Hans-Erik Lundgren, Björn Pilebro, Per Westermark, Jonas Wixner & Intissar Anan. (2019) Transthyretin Glu54Leu – an unknown mutation within the Swedish population associated with amyloid cardiomyopathy and a unique fibril type. Scandinavian Journal of Clinical and Laboratory Investigation 79:6, pages 372-376.
Read now
Read now
Ole B Suhr. (2019) Commentary to Isabel Conceição et al. early diagnosis through targeted follow-up of identified carriers of TTR gene mutations. Amyloid 26:1, pages 1-2.
Read now
Read now
Francesca Lavatelli & Giampaolo Merlini. (2016) Advances in proteomic study of cardiac amyloidosis: progress and potential. Expert Review of Proteomics 13:11, pages 1017-1027.
Read now
Read now
Kosuke Okumura, Taro Yamashita, Teruaki Masuda, Yohei Misumi, Akihiko Ueda, Mitsuharu Ueda, Konen Obayashi, Hirofumi Jono, Satoshi Yamashita, Yukihiro Inomata & Yukio Ando. (2016) Long-term outcome of patients with hereditary transthyretin V30M amyloidosis with polyneuropathy after liver transplantation. Amyloid 23:1, pages 39-45.
Read now
Read now
Akihiro Yanagisawa, Mitsuharu Ueda, Takanao Sueyoshi, Eiichi Nakamura, Masayoshi Tasaki, Genki Suenaga, Hiroaki Motokawa, Risa Toyoshima, Yumiko Kinoshita, Yohei Misumi, Taro Yamashita, Mitsuru Sakaguchi, Per Westermark, Hiroshi Mizuta & Yukio Ando. (2016) Knee osteoarthritis associated with different kinds of amyloid deposits and the impact of aging on type of amyloid. Amyloid 23:1, pages 26-32.
Read now
Read now
Björn Pilebro, Ole B. Suhr, Ulf Näslund, Per Westermark, Per Lindqvist & Torbjörn Sundström. (2016) 99mTc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis. Upsala Journal of Medical Sciences 121:1, pages 17-24.
Read now
Read now
Philip N. Hawkins, Yukio Ando, Angela Dispenzeri, Alejandra Gonzalez-Duarte, David Adams & Ole B. Suhr. (2015) Evolving landscape in the management of transthyretin amyloidosis. Annals of Medicine 47:8, pages 625-638.
Read now
Read now
Per Westermark, Gunilla T. Westermark, Ole B. Suhr & Svante Berg. (2014) Transthyretin-derived amyloidosis: Probably a common cause of lumbar spinal stenosis. Upsala Journal of Medical Sciences 119:3, pages 223-228.
Read now
Read now
Articles from other publishers (86)
Maximilian Steinebrei, Julian Baur, Anaviggha Pradhan, Niklas Kupfer, Sebastian Wiese, Ute Hegenbart, Stefan O. Schönland, Matthias Schmidt & Marcus Fändrich. (2023) Common transthyretin-derived amyloid fibril structures in patients with hereditary ATTR amyloidosis. Nature Communications 14:1.
Crossref
Crossref
Domitilla Russo, Francesco Cappelli, Gianluca Di Bella, Giacomo Tini, Aldostefano Porcari, Alberto Cipriani, Marco Canepa, Marco Merlo, Roberto Licordari, Pier Filippo Vianello, Mattia Zampieri, Laura De Michieli, Riccardo Scirpa, Federico Perfetto, Gianfranco Sinagra, Camillo Autore, Claudio Rapezzi & Maria Beatrice Musumeci. (2023) Electrocardiographic heterogeneity of patients with variant transthyretin amyloid cardiomyopathy: Genotype-phenotype correlations. International Journal of Cardiology, pages 131354.
Crossref
Crossref
Yukako Shintani-Domoto, Koji L. Ode, Seitaro Nomura, Hiroyuki Abe, Hiroki R. Ueda, Takashi Sakatani & Ryuji Ohashi. (2023) Elucidation of the mechanism of amyloid A and transthyretin formation using mass spectrometry-based absolute quantification. Virchows Archiv.
Crossref
Crossref
Paolo Morfino, Alberto Aimo, Giuseppe Vergaro, Chiara Sanguinetti, Vincenzo Castiglione, Maria Franzini, Marco Alfonso Perrone & Michele Emdin. (2023) Transthyretin Stabilizers and Seeding Inhibitors as Therapies for Amyloid Transthyretin Cardiomyopathy. Pharmaceutics 15:4, pages 1129.
Crossref
Crossref
Rivka Goldis, Batia Kaplan, Olga (Lesya) Kukuy, Michael Arad, Hila Magen, Efrat Shavit-Stein, Amir Dori & Avi Livneh. (2023) Diagnostic Challenges and Solutions in Systemic Amyloidosis. International Journal of Molecular Sciences 24:5, pages 4655.
Crossref
Crossref
Qunchao Ma, Mengdie Wang, Yanan Huang, Ying Nie, Xin Zhang, Dan Dan Yang, Zhuo Wang, Siyin Ding, Ningjing Qian, Yu Liu & Xiaohong Pan. (2023) Identification of a novel transthyretin mutation D39Y in a cardiac amyloidosis patient and its biochemical characterizations. Frontiers in Cardiovascular Medicine 10.
Crossref
Crossref
Atsushi Mori, Yukihiro Saito, Kazufumi Nakamura, Toshihiro Iida, Satoshi Akagi, Masashi Yoshida, Makiko Taniyama, Toru Miyoshi & Hiroshi Ito. (2023) Microcalcification and 99mTc-Pyrophosphate Uptake without Increased Bone Metabolism in Cardiac Tissue from Patients with Transthyretin Cardiac Amyloidosis. International Journal of Molecular Sciences 24:3, pages 1921.
Crossref
Crossref
Laura Acquasaliente & Vincenzo De Filippis. (2022) The Role of Proteolysis in Amyloidosis. International Journal of Molecular Sciences 24:1, pages 699.
Crossref
Crossref
Mario Nuvolone, Maria Girelli & Giampaolo Merlini. (2022) Oral Therapy for the Treatment of Transthyretin-Related Amyloid Cardiomyopathy. International Journal of Molecular Sciences 23:24, pages 16145.
Crossref
Crossref
Mattia Riefolo, Matteo Conti, Simone Longhi, Benedetta Fabbrizio & Ornella Leone. (2022) Amyloidosis: What does pathology offer? The evolving field of tissue biopsy. Frontiers in Cardiovascular Medicine 9.
Crossref
Crossref
Jignesh K. Patel, Andrew M. Rosen, Adam Chamberlin, Benjamin Feldmann, Christian Antolik, Heather Zimmermann, Tami Johnston & Arvind Narayana. (2022) Three Newly Recognized Likely Pathogenic Gene Variants Associated with Hereditary Transthyretin Amyloidosis. Neurology and Therapy 11:4, pages 1595-1607.
Crossref
Crossref
Francisca Pinheiro, Irantzu Pallarès, Francesca Peccati, Adrià Sánchez-Morales, Nathalia Varejão, Filipa Bezerra, David Ortega-Alarcon, Danilo Gonzalez, Marcelo Osorio, Susanna Navarro, Adrián Velázquez-Campoy, Maria Rosário Almeida, David Reverter, Félix Busqué, Ramon Alibés, Mariona Sodupe & Salvador Ventura. (2022) Development of a Highly Potent Transthyretin Amyloidogenesis Inhibitor: Design, Synthesis, and Evaluation. Journal of Medicinal Chemistry 65:21, pages 14673-14691.
Crossref
Crossref
Anvesh K. R. Dasari, Sujung Yi, Matthew F. Coats, Sungsool Wi & Kwang Hun Lim. (2022) Toxic Misfolded Transthyretin Oligomers with Different Molecular Conformations Formed through Distinct Oligomerization Pathways. Biochemistry 61:21, pages 2358-2365.
Crossref
Crossref
Paolo Morfino, Alberto Aimo, Giorgia Panichella, Claudio Rapezzi & Michele Emdin. (2022) Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis. Heart Failure Reviews 27:6, pages 2187-2200.
Crossref
Crossref
Maximilian Steinebrei, Juliane Gottwald, Julian Baur, Christoph Röcken, Ute Hegenbart, Stefan Schönland & Matthias Schmidt. (2022) Cryo-EM structure of an ATTRwt amyloid fibril from systemic non-hereditary transthyretin amyloidosis. Nature Communications 13:1.
Crossref
Crossref
Rishabh Chaudhary, Mujeeba Rehman, Vipul Agarwal, Arjun Singh Kaushik & Vikas Mishra. 2022. Neurodegenerative Diseases: Multifactorial Degenerative Processes, Biomarkers and Therapeutic Approaches (First Edition). Neurodegenerative Diseases: Multifactorial Degenerative Processes, Biomarkers and Therapeutic Approaches (First Edition)
26
58
.
Sadao Hikishima, Kenji Sakai, Akio Akagi, Hiroki Yamaguchi, Shutaro Shibata, Koji Hayashi, Hiroto Nakano, Mizuki Kanemoto, Yuta Usui, Yu Taniguchi, Junji Komatsu, Keiko Nakamura-Shindo, Ichiro Nozaki, Tsuyoshi Hamaguchi, Kenjiro Ono, Kazuo Iwasa & Masahito Yamada. (2022) Deterioration after Liver Transplantation and Transthyretin Stabilizer Administration in a Patient with ATTRv Amyloidosis with a Leu58Arg (p.Leu78Arg) <i>TTR</i> Variant. Internal Medicine 61:15, pages 2347-2351.
Crossref
Crossref
Elsa Arnberg, Per Eldhagen, Viktor Löfbacka, Ashwin Venkateshvaran, Björn Pilebro & Per Lindqvist. (2022) RWT/SaVR—A Simple and Highly Accurate Measure Screening for Transthyretin Cardiac Amyloidosis. Journal of Clinical Medicine 11:14, pages 4120.
Crossref
Crossref
Kang Du, Xujun Chu, Yuwei Tang, Xutong Zhao, Meng Yu, Yiming Zheng, Jianwen Deng, He Lv, Wei Zhang, Zhaoxia Wang, Yun Yuan & Lingchao Meng. (2022) Patterns of myelinated nerve fibers loss in transthyretin amyloid polyneuropathy and mimics. Annals of Clinical and Translational Neurology 9:7, pages 1059-1068.
Crossref
Crossref
Zhenghua Li & Kenichi Yamamura. (2022) Dissecting pathophysiology of a human dominantly inherited disease, familial amyloidotic polyneuropathy, by using genetically engineered mice. Frigid Zone Medicine 2:2, pages 65-75.
Crossref
Crossref
Mitsuharu Ueda. (2022) Transthyretin: Its function and amyloid formation. Neurochemistry International 155, pages 105313.
Crossref
Crossref
Ulrika Thelander, Gunilla T. Westermark, Gunnar Antoni, Sergio Estrada, Alice Zancanaro, Elisabet Ihse & Per Westermark. (2022) Cardiac microcalcifications in transthyretin (ATTR) amyloidosis. International Journal of Cardiology 352, pages 84-91.
Crossref
Crossref
Intissar Anan, Ole B. Suhr, Katarzyna Liszewska, Jorge Mejia Baranda, Björn Pilebro, Jonas Wixner & Elisabet Ihse. (2022) Amyloid fibril composition type is consistent over time in patients with Val30Met (p.Val50Met) transthyretin amyloidosis. PLOS ONE 17:3, pages e0266092.
Crossref
Crossref
Giulia Faravelli, Valentina Mondani, P. Patrizia Mangione, Sara Raimondi, Loredana Marchese, Francesca Lavatelli, Monica Stoppini, Alessandra Corazza, Diana Canetti, Guglielmo Verona, Laura Obici, Graham W. Taylor, Julian D. Gillmore, Sofia Giorgetti & Vittorio Bellotti. (2022) Amyloid Formation by Globular Proteins: The Need to Narrow the Gap Between in Vitro and in Vivo Mechanisms. Frontiers in Molecular Biosciences 9.
Crossref
Crossref
Irina Iakovleva, Michael Hall, Melanie Oelker, Linda Sandblad, Intissar Anan & A. Elisabeth Sauer-Eriksson. (2021) Structural basis for transthyretin amyloid formation in vitreous body of the eye. Nature Communications 12:1.
Crossref
Crossref
Ivana Slamova, Rozita Adib, Stephan Ellmerich, Michal R. Golos, Janet A. Gilbertson, Nicola Botcher, Diana Canetti, Graham W. Taylor, Nigel Rendell, Glenys A. Tennent, Guglielmo Verona, Riccardo Porcari, P. Patrizia Mangione, Julian D. Gillmore, Mark B. Pepys, Vittorio Bellotti, Philip N. Hawkins, Raya Al-Shawi & J. Paul Simons. (2021) Plasmin activity promotes amyloid deposition in a transgenic model of human transthyretin amyloidosis. Nature Communications 12:1.
Crossref
Crossref
Márcia Waddington-Cruz, Jonas Wixner, Leslie Amass, Jan Kiszko, Doug Chapman, Yukio Ando, Fabio Adrian Barroso, Marcelo Rugiero, Johan Van Cleemput, Ivaylo Tarnev, Theodoros Kyriakides, Arnt Kristen, Hartmut Schmidt, Felix Darstein, Burkhard Gess, Josep Maria Campistol Plana, Juan Gonzalez Moreno, Jose Gonzalez Costello, Pablo Garcia Pavia, Roberto Fernandéz Torrón, Francisco Munoz Beamud, Violaine Planté-Bordeneuve, David Adams, Olivier Lairez, Claudio Rapezzi, Giampaolo Merlini, Marco Luigetti, Yoshiki Sekijima, Taro Yamashita, Sonoko Misawa, Soon Chai Low, Hans Nienhuis, Teresa Coelho, Isabel Conceição, Rayomand Press, Yesim Parman, Mathew Maurer, Stephen Gottlieb, Annabel Wang, Brian Drachman, Angela Dispenzieri, Sasa Zivkovic & Daniel Lenihan. (2021) Characteristics of Patients with Late- vs. Early-Onset Val30Met Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey (THAOS). Neurology and Therapy 10:2, pages 753-766.
Crossref
Crossref
Takeshi Yokoyama, Mirai Kashihara & Mineyuki Mizuguchi. (2021) Repositioning of the Anthelmintic Drugs Bithionol and Triclabendazole as Transthyretin Amyloidogenesis Inhibitors. Journal of Medicinal Chemistry 64:19, pages 14344-14357.
Crossref
Crossref
Filipa Bezerra, Christoph Niemietz, Hartmut H. J. Schmidt, Andree Zibert, Shuling Guo, Brett P. Monia, Paula Gonçalves, Maria João Saraiva & Maria Rosário Almeida. (2021) In Vitro and In Vivo Effects of SerpinA1 on the Modulation of Transthyretin Proteolysis. International Journal of Molecular Sciences 22:17, pages 9488.
Crossref
Crossref
P. Eldhagen, S. Berg, L.H. Lund, P. Sörensson, O.B. Suhr & P. Westermark. (2021) Transthyretin amyloid deposits in lumbar spinal stenosis and assessment of signs of systemic amyloidosis. Journal of Internal Medicine 289:6, pages 895-905.
Crossref
Crossref
Maike F. Dohrn, Sandra Ihne, Ute Hegenbart, Jessica Medina, Stephan L. Züchner, Teresa Coelho & Katrin Hahn. (2020) Targeting transthyretin ‐ Mechanism‐based treatment approaches and future perspectives in hereditary amyloidosis. Journal of Neurochemistry 156:6, pages 802-818.
Crossref
Crossref
Marianna Bruno, Adam Castaño, Arianna Burton & Justin L. Grodin. (2020) Transthyretin amyloid cardiomyopathy in women: frequency, characteristics, and diagnostic challenges. Heart Failure Reviews 26:1, pages 35-45.
Crossref
Crossref
Filipa Bezerra, Maria João Saraiva & Maria Rosário Almeida. (2020) Modulation of the Mechanisms Driving Transthyretin Amyloidosis. Frontiers in Molecular Neuroscience 13.
Crossref
Crossref
Daniele Peterle, Giulia Pontarollo, Stefano Spada, Paola Brun, Luana Palazzi, Alexej V. Sokolov, Barbara Spolaore, Patrizia Polverino de Laureto, Vadim B. Vasilyev, Ignazio Castagliuolo & Vincenzo De Filippis. (2020) A serine protease secreted from Bacillus subtilis cleaves human plasma transthyretin to generate an amyloidogenic fragment. Communications Biology 3:1.
Crossref
Crossref
Takeshi Yokoyama & Mineyuki Mizuguchi. (2020) Transthyretin Amyloidogenesis Inhibitors: From Discovery to Current Developments. Journal of Medicinal Chemistry 63:23, pages 14228-14242.
Crossref
Crossref
Hedvig Paulsson Rokke, Nima Sadat Gousheh, Per Westermark, Ole B. Suhr, Intissar Anan, Elisabet Ihse, Björn Pilebro & Jonas Wixner. (2020) Abdominal fat pad biopsies exhibit good diagnostic accuracy in patients with suspected transthyretin amyloidosis. Orphanet Journal of Rare Diseases 15:1.
Crossref
Crossref
Sara Raimondi, P. Patrizia Mangione, Guglielmo Verona, Diana Canetti, Paola Nocerino, Loredana Marchese, Rebecca Piccarducci, Valentina Mondani, Giulia Faravelli, Graham W. Taylor, Julian D. Gillmore, Alessandra Corazza, Mark B. Pepys, Sofia Giorgetti & Vittorio Bellotti. (2020) Comparative study of the stabilities of synthetic in vitro and natural ex vivo transthyretin amyloid fibrils. Journal of Biological Chemistry 295:33, pages 11379-11387.
Crossref
Crossref
Ahmad Masri, Syed Bukhari, Yvonne S. Eisele & Prem Soman. (2020) Molecular Imaging of Cardiac Amyloidosis. Journal of Nuclear Medicine 61:7, pages 965-970.
Crossref
Crossref
Anvesh K. R. Dasari, Jenette Arreola, Brian Michael, Robert G. Griffin, Jeffery W. Kelly & Kwang Hun Lim. (2020) Disruption of the CD Loop by Enzymatic Cleavage Promotes the Formation of Toxic Transthyretin Oligomers through a Common Transthyretin Misfolding Pathway. Biochemistry 59:25, pages 2319-2327.
Crossref
Crossref
Maria Beatrice Musumeci, Francesco Cappelli, Domitilla Russo, Giacomo Tini, Marco Canepa, Agnese Milandri, Rachele Bonfiglioli, Gianluca Di Bella, Filomena My, Marco Luigetti, Marina Grandis, Camillo Autore, Stefano Perlini, Federico Perfetto & Claudio Rapezzi. (2020) Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis. JACC: Cardiovascular Imaging 13:6, pages 1314-1321.
Crossref
Crossref
Anvesh K. R. Dasari, Ivan Hung, Brian Michael, Zhehong Gan, Jeffery W. Kelly, Lawreen H. Connors, Robert G. Griffin & Kwang Hun Lim. (2020) Structural Characterization of Cardiac Ex Vivo Transthyretin Amyloid: Insight into the Transthyretin Misfolding Pathway In Vivo. Biochemistry 59:19, pages 1800-1803.
Crossref
Crossref
Ahmad MasriSyed BukhariShahzad AhmadRicardo NievesYvonne S. EiseleWilliam FollansbeeAmy BrownellTimothy C. WongErik SchelbertPrem Soman. (2020) Efficient 1-Hour Technetium-99 m Pyrophosphate Imaging Protocol for the Diagnosis of Transthyretin Cardiac Amyloidosis. Circulation: Cardiovascular Imaging 13:2.
Crossref
Crossref
Jonah RubinMathew S. Maurer. (2020) Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable. Annual Review of Medicine 71:1, pages 203-219.
Crossref
Crossref
Sandra Ihne, Caroline Morbach, Laura Obici, Giovanni Palladini & Stefan Störk. (2019) Amyloidosis in Heart Failure. Current Heart Failure Reports 16:6, pages 285-303.
Crossref
Crossref
Matthias Schmidt, Sebastian Wiese, Volkan Adak, Jonas Engler, Shubhangi Agarwal, Günter Fritz, Per Westermark, Martin Zacharias & Marcus Fändrich. (2019) Cryo-EM structure of a transthyretin-derived amyloid fibril from a patient with hereditary ATTR amyloidosis. Nature Communications 10:1.
Crossref
Crossref
Marius Kollmer, William Close, Leonie Funk, Jay Rasmussen, Aref Bsoul, Angelika Schierhorn, Matthias Schmidt, Christina J. Sigurdson, Mathias Jucker & Marcus Fändrich. (2019) Cryo-EM structure and polymorphism of Aβ amyloid fibrils purified from Alzheimer’s brain tissue. Nature Communications 10:1.
Crossref
Crossref
Deepa M. Gopal, Frederick L. Ruberg & Omar K. Siddiqi. (2019) Impact of Genetic Testing in Transthyretin (ATTR) Cardiac Amyloidosis. Current Heart Failure Reports 16:5, pages 180-188.
Crossref
Crossref
Haruki Koike, Yuki Fukami, Ryoji Nishi, Yuichi Kawagashira, Masahiro Iijima, Gen Sobue & Masahisa Katsuno. (2019) Clinicopathological spectrum and recent advances in the treatment of hereditary transthyretin amyloidosis. Neurology and Clinical Neuroscience 7:4, pages 166-173.
Crossref
Crossref
Mitsuharu Ueda, Masamitsu Okada, Mineyuki Mizuguchi, Barbara Kluve-Beckerman, Kyosuke Kanenawa, Aito Isoguchi, Yohei Misumi, Masayoshi Tasaki, Akihiko Ueda, Akinori Kanai, Ryoko Sasaki, Teruaki Masuda, Yasuteru Inoue, Toshiya Nomura, Satoru Shinriki, Tsuyoshi Shuto, Hirofumi Kai, Taro Yamashita, Hirotaka Matsui, Merrill D. Benson & Yukio Ando. (2019) A cell-based high-throughput screening method to directly examine transthyretin amyloid fibril formation at neutral pH. Journal of Biological Chemistry 294:29, pages 11259-11275.
Crossref
Crossref
David Adams, Haruki Koike, Michel Slama & Teresa Coelho. (2019) Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease. Nature Reviews Neurology 15:7, pages 387-404.
Crossref
Crossref
Ole Bernt Suhr, Jonas Wixner, Intissar Anan, Hans-Erik Lundgren, Priyantha Wijayatunga, Per Westermark & Elisabet Ihse. (2019) Amyloid fibril composition within hereditary Val30Met (p. Val50Met) transthyretin amyloidosis families. PLOS ONE 14:2, pages e0211983.
Crossref
Crossref
Ai Woon Yee, Matteo Aldeghi, Matthew P. Blakeley, Andreas Ostermann, Philippe J. Mas, Martine Moulin, Daniele de Sanctis, Matthew W. Bowler, Christoph Mueller-Dieckmann, Edward P. Mitchell, Michael Haertlein, Bert L. de Groot, Elisabetta Boeri Erba & V. Trevor Forsyth. (2019) A molecular mechanism for transthyretin amyloidogenesis. Nature Communications 10:1.
Crossref
Crossref
Haruki Koike & Masahisa Katsuno. (2019) Ultrastructure in Transthyretin Amyloidosis: From Pathophysiology to Therapeutic Insights. Biomedicines 7:1, pages 11.
Crossref
Crossref
Yoshiki Sekijima, Mitsuharu Ueda, Haruki Koike, Sonoko Misawa, Tomonori Ishii & Yukio Ando. (2018) Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm. Orphanet Journal of Rare Diseases 13:1.
Crossref
Crossref
Teodorico C. Ramalho, Alexandre A. de Castro, Tássia S. Tavares, Maria C. Silva, Daniela R. Silva, Pedro H. Cesar, Lucas A. Santos, Elaine F.F. da Cunha, Eugenie Nepovimova & Kamil Kuca. (2018) Insights into the pharmaceuticals and mechanisms of neurological orphan diseases: Current Status and future expectations. Progress in Neurobiology 169, pages 135-157.
Crossref
Crossref
P. Patrizia Mangione, Guglielmo Verona, Alessandra Corazza, Julien Marcoux, Diana Canetti, Sofia Giorgetti, Sara Raimondi, Monica Stoppini, Marilena Esposito, Annalisa Relini, Claudio Canale, Maurizia Valli, Loredana Marchese, Giulia Faravelli, Laura Obici, Philip N. Hawkins, Graham W. Taylor, Julian D. Gillmore, Mark B. Pepys & Vittorio Bellotti. (2018) Plasminogen activation triggers transthyretin amyloidogenesis in vitro. Journal of Biological Chemistry 293:37, pages 14192-14199.
Crossref
Crossref
Lorena Saelices, Kevin ChungJi H. LeeWhitaker CohnJulian P. WhiteleggeMerrill D. Benson & David S. Eisenberg. (2018) Amyloid seeding of transthyretin by ex vivo cardiac fibrils and its inhibition. Proceedings of the National Academy of Sciences 115:29.
Crossref
Crossref
Elena S. KlimtchukTatiana ProkaevaNicholas M. FrameHassan A. AbdullahiBrian SpencerSurendra DasariHaili CuiJohn L. BerkPaul J. Kurtin, Lawreen H. ConnorsOlga Gursky. (2018) Unusual duplication mutation in a surface loop of human transthyretin leads to an aggressive drug-resistant amyloid disease. Proceedings of the National Academy of Sciences 115:28.
Crossref
Crossref
Björn Pilebro, Sandra Arvidsson, Per Lindqvist, Torbjörn Sundström, Per Westermark, Gunnar Antoni, Ole Suhr & Jens Sörensen. (2016) Positron emission tomography (PET) utilizing Pittsburgh compound B (PIB) for detection of amyloid heart deposits in hereditary transthyretin amyloidosis (ATTR). Journal of Nuclear Cardiology 25:1, pages 240-248.
Crossref
Crossref
Gunilla T. Westermark, Marcus Fändrich, Katarzyna Lundmark & Per Westermark. (2018) Noncerebral Amyloidoses: Aspects on Seeding, Cross-Seeding, and Transmission. Cold Spring Harbor Perspectives in Medicine 8:1, pages a024323.
Crossref
Crossref
Matteo Conti, Irene Poppi, Thomas Matulli Cavedagna, Elena Zamagni, Ornella Leone, Barbara Corti, Agnese Milandri, Francesco Bacci, Eric Ramazzotti, Rita Mancini, Michele Cavo, Candida Cristina Quarta & Claudio Rapezzi. (2018) A targeted proteomics approach to amyloidosis typing. Clinical Mass Spectrometry 7, pages 18-28.
Crossref
Crossref
Taro Yamashita, Mitsuharu Ueda, Yohei Misumi, Teruaki Masuda, Toshiya Nomura, Masayoshi Tasaki, Kotaro Takamatsu, Keiko Sasada, Konen Obayashi, Hirotaka Matsui & Yukio Ando. (2017) Genetic and clinical characteristics of hereditary transthyretin amyloidosis in endemic and non-endemic areas: experience from a single-referral center in Japan. Journal of Neurology 265:1, pages 134-140.
Crossref
Crossref
Gunilla T. Westermark, Elisabet Ihse & Per Westermark. 2018. Amyloid Proteins. Amyloid Proteins
401
414
.
O. B. Suhr, E. Lundgren & P. Westermark. (2017) One mutation, two distinct disease variants: unravelling the impact of transthyretin amyloid fibril composition. Journal of Internal Medicine 281:4, pages 337-347.
Crossref
Crossref
Guglielmo Verona, P. Patrizia Mangione, Sara Raimondi, Sofia Giorgetti, Giulia Faravelli, Riccardo Porcari, Alessandra Corazza, Julian D. Gillmore, Philip N. Hawkins, Mark B. Pepys, Graham W. Taylor & Vittorio Bellotti. (2017) Inhibition of the mechano-enzymatic amyloidogenesis of transthyretin: role of ligand affinity, binding cooperativity and occupancy of the inner channel. Scientific Reports 7:1.
Crossref
Crossref
Natalie J. Galant, Per Westermark, Jeffrey N. HigakiAvijit Chakrabartty. (2017) Transthyretin amyloidosis: an under-recognized neuropathy and cardiomyopathy. Clinical Science 131:5, pages 395-409.
Crossref
Crossref
Keyur B. ShahAnit K. MankadAdam CastanoOlakunle O. AkinboboyePhillip B. DuncanIcilma V. FergusMathew S. Maurer. (2016) Transthyretin Cardiac Amyloidosis in Black Americans. Circulation: Heart Failure 9:6.
Crossref
Crossref
Teresa Coelho, Giampaolo Merlini, Christine E. Bulawa, James A. Fleming, Daniel P. Judge, Jeffery W. Kelly, Mathew S. Maurer, Violaine Planté-Bordeneuve, Richard Labaudinière, Rajiv Mundayat, Steve Riley, Ilise Lombardo & Pedro Huertas. (2016) Mechanism of Action and Clinical Application of Tafamidis in Hereditary Transthyretin Amyloidosis. Neurology and Therapy 5:1, pages 1-25.
Crossref
Crossref
Patrik Nordeman, Leif B. G. Johansson, Marcus Bäck, Sergio Estrada, Håkan Hall, Daniel Sjölander, Gunilla T. Westermark, Per Westermark, Lars Nilsson, Per Hammarström, K. Peter R. Nilsson & Gunnar Antoni. (2016)
11
C and
18
F Radiolabeling of Tetra- and Pentathiophenes as PET-Ligands for Amyloid Protein Aggregates
. ACS Medicinal Chemistry Letters 7:4, pages 368-373.
Crossref
Crossref
Isabel Conceição, Alejandra González‐Duarte, Laura Obici, Hartmut H.‐J. Schmidt, Damien Simoneau, Moh‐Lim Ong & Leslie Amass. (2016) “Red‐flag” symptom clusters in transthyretin familial amyloid polyneuropathy. Journal of the Peripheral Nervous System 21:1, pages 5-9.
Crossref
Crossref
Ole B. Suhr, Marie Larsson, Bo-Göran Ericzon & Henryk E. Wilczek. (2016) Survival After Transplantation in Patients With Mutations Other Than Val30Met. Transplantation 100:2, pages 373-381.
Crossref
Crossref
Per Westermark. (2015) Do we need to demonstrate amyloid in tissue for hereditary ATTR amyloidosis ?. Orphanet Journal of Rare Diseases 10:S1.
Crossref
Crossref
Sandra Arvidsson, Björn Pilebro, Per Westermark, Per Lindqvist & Ole B. Suhr. (2015) Amyloid Cardiomyopathy in Hereditary Transthyretin V30M Amyloidosis - Impact of Sex and Amyloid Fibril Composition. PLOS ONE 10:11, pages e0143456.
Crossref
Crossref
Julien Marcoux, P Patrizia Mangione, Riccardo Porcari, Matteo T Degiacomi, Guglielmo Verona, Graham W Taylor, Sofia Giorgetti, Sara Raimondi, Sarah Sanglier‐Cianférani, Justin LP Benesch, Ciro Cecconi, Mohsin M Naqvi, Julian D Gillmore, Philip N Hawkins, Monica Stoppini, Carol V Robinson, Mark B Pepys & Vittorio Bellotti. (2015) A novel mechano‐enzymatic cleavage mechanism underlies transthyretin amyloidogenesis. EMBO Molecular Medicine 7:10, pages 1337-1349.
Crossref
Crossref
Yoshiki Sekijima. (2015) Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments. Journal of Neurology, Neurosurgery & Psychiatry 86:9, pages 1036-1043.
Crossref
Crossref
Bo-Göran Ericzon, Henryk E. Wilczek, Marie Larsson, Priyantha Wijayatunga, Arie Stangou, João Rodrigues Pena, Emanuel Furtado, Eduardo Barroso, Jorge Daniel, Didier Samuel, Rene Adam, Vincent Karam, John Poterucha, David Lewis, Ben-Hur Ferraz-Neto, Márcia Waddington Cruz, Miguel Munar-Ques, Juan Fabregat, Shu-ichi Ikeda, Yukio Ando, Nigel Heaton, Gerd Otto & Ole Suhr. (2015) Liver Transplantation for Hereditary Transthyretin Amyloidosis. Transplantation 99:9, pages 1847-1854.
Crossref
Crossref
Marie-Pierre Jamet, Viviane Gnemmi, Éric Hachulla, Claire-Marie Dhaenens, Brigitte Bouchindhomme, Claire Delattre, François Glowacki, Pierre-Yves Hatron, Arnaud Lacour, Nicolas Lamblin, David Launay, Xavier Leleu, Anne Guiochon-Mantel, Sophie Valleix, Claude-Alain Maurage, Marie-Christine Copin & David Buob. (2015) Distinctive Patterns of Transthyretin Amyloid in Salivary Tissue. American Journal of Surgical Pathology 39:8, pages 1035-1044.
Crossref
Crossref
Gonçalo da Costa, Cristina Ribeiro-Silva, Raquel Ribeiro, Samuel Gilberto, Ricardo A. Gomes, António Ferreira, Élia Mateus, Eduardo Barroso, Ana V. Coelho, Ana Ponces Freire & Carlos Cordeiro. (2015) Transthyretin Amyloidosis: Chaperone Concentration Changes and Increased Proteolysis in the Pathway to Disease. PLOS ONE 10:7, pages e0125392.
Crossref
Crossref
Irina Iakovleva, Afshan Begum, Malgorzata Pokrzywa, Malin Walfridsson, A. Elisabeth Sauer-Eriksson & Anders Olofsson. (2015) The Flavonoid Luteolin, but Not Luteolin-7-O-Glucoside, Prevents a Transthyretin Mediated Toxic Response. PLOS ONE 10:5, pages e0128222.
Crossref
Crossref
Monica Stoppini & Vittorio Bellotti. (2015) Systemic Amyloidosis: Lessons from β2-Microglobulin. Journal of Biological Chemistry 290:16, pages 9951-9958.
Crossref
Crossref
Urban Hellman, Hans-Erik Lundgren, Per Westermark, Christina Stafberg, Hareth Nahi, Sascha Tachlinski, Michael Guggi, Max Flogegård, Mehmet Hamid, Stefan A. Escher & Ole B. Suhr. (2015) A genealogical and clinical study of the phenotypical variation within the Swedish transthyretin His88Arg (p. His108Arg) amyloidosis family. European Journal of Medical Genetics 58:4, pages 211-215.
Crossref
Crossref
Claudio Rapezzi, Massimiliano Lorenzini, Simone Longhi, Agnese Milandri, Christian Gagliardi, Ilaria Bartolomei, Fabrizio Salvi & Mathew S. Maurer. (2015) Cardiac amyloidosis: the great pretender. Heart Failure Reviews 20:2, pages 117-124.
Crossref
Crossref
Akihiro Yanagisawa, Mitsuharu Ueda, Takanao Sueyoshi, Tatsuya Okada, Toru Fujimoto, Yasuhiro Ogi, Keisuke Kitagawa, Masayoshi Tasaki, Yohei Misumi, Toshinori Oshima, Hirofumi Jono, Konen Obayashi, Kei Hirakawa, Hitoshi Uchida, Per Westermark, Yukio Ando & Hiroshi Mizuta. (2015) Amyloid deposits derived from transthyretin in the ligamentum flavum as related to lumbar spinal canal stenosis. Modern Pathology 28:2, pages 201-207.
Crossref
Crossref
Johan Bijzet, Ingrid I. van Gameren & Bouke P. C. Hazenberg. 2015. Amyloid and Related Disorders. Amyloid and Related Disorders
229
248
.
P. Patrizia MangioneRiccardo PorcariJulian D. GillmorePiero PucciMaria MontiMattia PorcariSofia GiorgettiLoredana MarcheseSara RaimondiLouise C. SerpellWenjie Chen, Annalisa Relini, Julien Marcoux, Innes R. ClatworthyGraham W. TaylorGlenys A. TennentCarol V. Robinson, Philip N. HawkinsMonica StoppiniStephen P. Wood, Mark B. PepysVittorio Bellotti. (2014) Proteolytic cleavage of Ser52Pro variant transthyretin triggers its amyloid fibrillogenesis. Proceedings of the National Academy of Sciences 111:4, pages 1539-1544.
Crossref
Crossref
Francesca Lavatelli, Riccardo Albertini, Andrea Di Fonzo, Giovanni Palladini & Giampaolo Merlini. (2014) Biochemical markers in early diagnosis and management of systemic amyloidoses. Clinical Chemistry and Laboratory Medicine (CCLM) 52:11.
Crossref
Crossref